Jubilant Ingrevia commissions new Acetic Anhydride plant at Bharuch facility
Noida: Jubilant Ingrevia Limited, has announced the commissioning of its new globalscale Acetic Anhydride plant, at its manufacturing facility in west India at Bharuch, Gujarat.
This plant adds around 60,000 MT of capacity, whereby scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT.
"This enhanced capacity will also help the Company to increase its global presence in various geographies and achieve leadership position in the global merchant markets. In the domestic market it further strengthens and consolidates Jubilant Ingrevia Limited’s position as a market leader," the company stated.
For several decades now, Jubilant Ingrevia Limited has been regarded as a ‘partner of choice’ globally for supplying Acetic Anhydride for various end‐usages.
"This facility augmentation will further strengthen the relationship that Jubilant Ingrevia Limited enjoys with its global clients. With this additional capacity, Jubilant Ingrevia Limited also provides opportunity to its global customers to further expand their downstream products across end‐user industries viz. Pharmaceuticals, Agrochemicals, Food, Vitamins, Wood Acetylation, Electronics, Dyes industry etc," Jubilant further stated.
Read also: Jubilant Draximage bags USFDA nod for Technetium Mertiatide Injection
On this occasion, Mr. Rajesh Srivastava, CEO & Managing Director, Jubilant Ingrevia Limited said, “We are pleased with the commissioning of our new global scale Acetic Anhydride plant. We are happy to see that our efforts to become a reliable supplier of Acetic Anhydride for international customers, is now showing significant results. This has led us to the decision to add a new plant with global scale capacity and hence achieve leadership in Acetic Anhydride’s global merchant market. With our well‐established global distribution network, this additional capacity of Acetic Anhydride will further ensure sufficient feedstock availability for our various global customers for their end products, as well as help them achieve their desired growth across global markets.”
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.